We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

A Personalized Microfluidic Model for Kidney Cancer Drug Screening

News   Apr 04, 2019 | Original story from the University of Wisconsin-Madison

 
A Personalized Microfluidic Model for Kidney Cancer Drug Screening

Tumor and normal tissue are removed from the patient during surgery, the cells are isolated, and then injected into the lumen device created by the Beebe lab. There they grew into three-dimensional models of kidney cancer blood vessels. Image credit: University of Wisconsin-Madison

 
 
 

RELATED ARTICLES

Brain Cells Can Halt Muscle Wastage, Suggests Worm Study

News

In a worm model, researchers have found brain cells that may help to clean up aggregation associated with neurodegenerations and muscle wastage.

READ MORE

Tracking Iron Levels in the Brain Could Reveal Parkinson's Progress

News

Using a novel MRI technique, researchers have demonstrated that it may be possible to track the progression of Parkinson’s by detection of iron deposits.

READ MORE

Shaping the Rings of Molecules

News

Scientists report that they have succeeded in using a natural process called biocatalysis to control the shapes of macrocycles. These molecules can be used to create pharmaceutical and electronics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE